Topic:
Latest Headlines
Over the course of five years as U.S. Attorney for the Eastern District of Tennessee, Bill Killian collected more than $200 million from healthcare fraud cases alone, and saw five-fold increase in civil claims. However, he argues that healthcare fraud isn't increasing--state and federal agencies are just getting better and detecting it. Following his resignation as U.S. Attorney, FierceHealthPayer: Antifraud spoke with Killian about some of the important healthcare fraud trends and where the government is directing most of its attention.
A collaborative effort that included both public and private legal teams was a critical element in forcing Novartis into a $390 million settlement finalized last month, according to a Bloomberg BNA Q&A with one of the whistleblower attorneys involved in the case.
A Utah-based pharmaceutical wholesaler has been charged for his role in a complex fraud scheme in which he is accused of reselling medications purchased on the black market, triggering tens of millions of illegitimate charges Medicaid programs, according to the Department of Justice.
A New Jersey man has been charged with using a non-profit company to gain entrance to community centers across the state, where he convinced elderly residents to get unnecessary genetic tests that were billed to Medicare.
The second-highest biller for power wheelchairs received nearly $27 million in improper Medicare payments in 2010, according to a report from the Office of Inspector General.
Ten former employees of a Virginia counseling provider have been sentenced to varying prison terms over the past year for submitting false claims to the state's Medicaid program.
Partnerships between assisted living facilities and home health companies are a natural fit based on their respective roles within the post-acute care environment, but those partnerships can also lead anti-kickback violations, intentional or otherwise.
The Office of Inspector General is recovering less money from fraud investigations, but the agency is clearly shifting its focus toward civil actions, according to information included in the OIG's Semiannual Report to Congress.
When a company pays millions to settle False Claims Act allegations, where does that money go? That answer might be more convoluted than you think, according to an article by BioPharmaDive.
Nearly 70 percent of healthcare, pharmaceutical, and biotechnology executives around the world said their company was affected by fraud during the past year, according to a report from Kroll. However, only 36 percent reported they would be investing in management controls in the coming year.
Press Releases
- Statement by Theranos on CMS Audit Results
- MISSING PIECES: MAJOR HEALTH DATABASE HAS DEEP FLAWS
- Majority of Americans Don't Use Digital Technology to Access their Doctors
- Home Care Alliance of Massachusetts Launches HIT Adoption Initiative
- Veterans Health Administration and Indian Health Service Become First Federal Agencies to Gain Interoperability via DirectExchange
- More Press Releases
Sponsored Links